Demonstration of two distinct subsets of gastric varices. Observations during a seven-year study of endoscopic sclerotherapy
- PMID: 1995266
- DOI: 10.1007/BF01318201
Demonstration of two distinct subsets of gastric varices. Observations during a seven-year study of endoscopic sclerotherapy
Abstract
Over a seven-year period, assessment of gastric varices was made on 225 patients receiving endoscopic sclerotherapy for variceal hemorrhage. Of 170 patients with complete data, gastric varices were observed in 26 (15.3%). Importantly, two distinct subsets of gastric varices were identified: varices distal to the gastroesophageal junction without extension into the fundus, termed "junctional varices," occurred in 11.2%, and varices that were confined only to the fundus, termed "fundal varices," occurred less frequently in 4.1%. Although rebleeding was increased in both subsets of gastric varices, junctional varices were more amenable to sclerotherapy. Patients with fundal varices (N = 7) had a significantly higher rebleeding rate, increased complications with sclerotherapy, and significantly decreased survival (P less than 0.005) when compared to patients with esophageal varices alone (N = 87) who were followed for more than three months. Cumulative survival was not significantly different (P less than 0.08) in patients with junctional varices (N = 19) when compared with patients with esophageal varices alone. We conclude that not all patients with gastric varices have a poor result with sclerotherapy. Recognition of these subsets may improve treatment strategies in patients with gastric varices.
Similar articles
-
Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience.Gastrointest Endosc. 1997 Jul;46(1):8-14. doi: 10.1016/s0016-5107(97)70202-5. Gastrointest Endosc. 1997. PMID: 9260698 Clinical Trial.
-
Bucrylate treatment of bleeding gastric varices: 12 years' experience.Endoscopy. 2000 Jul;32(7):512-9. doi: 10.1055/s-2000-3817. Endoscopy. 2000. PMID: 10917182
-
Variceal rebleeding and recurrence after endoscopic injection sclerotherapy: a prospective evaluation in 204 patients.Arch Surg. 2000 Nov;135(11):1315-22. doi: 10.1001/archsurg.135.11.1315. Arch Surg. 2000. PMID: 11074888
-
[Diagnosis and treatment of bleeding esophago-gastric varices].Nihon Rinsho. 1998 Sep;56(9):2325-30. Nihon Rinsho. 1998. PMID: 9780714 Review. Japanese.
-
Endoscopic variceal ligation compared with endoscopic injection sclerotherapy for treatment of esophageal variceal hemorrhage: a meta-analysis.World J Gastroenterol. 2015 Feb 28;21(8):2534-41. doi: 10.3748/wjg.v21.i8.2534. World J Gastroenterol. 2015. PMID: 25741164 Free PMC article. Review.
Cited by
-
Percutaneous transportal sclerotherapy with N-butyl-2-cyanoacrylate for gastric varices: technique and clinical efficacy.Korean J Radiol. 2008 Nov-Dec;9(6):526-33. doi: 10.3348/kjr.2008.9.6.526. Korean J Radiol. 2008. PMID: 19039269 Free PMC article.
-
Revision and update on clinical practice guideline for liver cirrhosis.Korean J Hepatol. 2012 Mar;18(1):1-21. doi: 10.3350/kjhep.2012.18.1.1. Epub 2012 Mar 22. Korean J Hepatol. 2012. PMID: 22511898 Free PMC article. No abstract available.
-
EVS vs TIPS shunt for gastric variceal bleeding in patients with cirrhosis: A meta-analysis.World J Gastrointest Pharmacol Ther. 2014 May 6;5(2):97-104. doi: 10.4292/wjgpt.v5.i2.97. World J Gastrointest Pharmacol Ther. 2014. PMID: 24868490 Free PMC article.
-
Beta-blockers in cirrhosis: Evidence-based indications and limitations.JHEP Rep. 2019 Dec 20;2(1):100063. doi: 10.1016/j.jhepr.2019.12.001. eCollection 2020 Feb. JHEP Rep. 2019. PMID: 32039404 Free PMC article. Review.
-
Randomized trials of endoscopic therapy and transjugular intrahepatic portosystemic shunt versus portacaval shunt for emergency and elective treatment of bleeding gastric varices in cirrhosis.Surgery. 2015 Jun;157(6):1028-45. doi: 10.1016/j.surg.2014.12.003. Surgery. 2015. PMID: 25957003 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical